What does the evidence say about Safflower Oil Lipids Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Safflower Oil Lipids Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - This paper examines the nutritional and metabolic characteristics of Carthamus tinctorius seed oils produced in two regions across Morocco and assesses how various extraction methods, Soxhlet, cold pressing, and maceration, affect oil yield and the presence of bioactive compounds, which establishes the data on Moroccan cultivars that have limited information. [El Kourchi C (2026); evidence level 4] - Soxhlet extraction provided the highest oil yield, with the oil being rich in linoleic acid (40.45% ± 0.17%-80.25% ± 0.16%), a polyunsaturated fatty acid. [El Kourchi C (2026); evidence level 4] - As the principal dietary source of lipids, edible oils (notably vegetable oils) exist in crude form predominantly as triacylglycerols (about 95%), with the remainder comprising impurities and diverse minor components. [Yang J (2025); evidence level 4] - The application potential of safflower seed oil (SSO) in both nutraceutical and pharmaceutical domains is attributed to its exceptionally high linoleic acid concentration and abundant polyphenolic constituents. [Yang J (2025); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.